Ignite Creation Date:
2024-05-06 @ 8:25 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06375187
Status:
RECRUITING
Last Update Posted:
2024-06-24
First Post:
2024-04-16
Brief Title:
Engineering Tumor Infiltrating Lymphocytes Injection GC203 TIL for the Treatment of Advanced Malignant Solid Tumors
Sponsor:
Shanghai Juncell Therapeutics
Organization:
Shanghai Juncell Therapeutics
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-29
Start Date Type:
ACTUAL
Primary Completion Date:
2025-11-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-05-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-16
First Submit QC Date:
April 16 2024
Study First Post Date:
2024-04-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-19
Last Update Post Date:
2024-06-24
Last Update Post Date Type:
ACTUAL